Comorbidities and Cardiovascular Risk Factors in Older Adults Undergoing Anticancer Therapy

In the dynamic landscape of healthcare, the broadcast 'Comorbidities and Cardiovascular Risk Factors in Older Adults Undergoing Anticancer Therapy' serves as an essential resource for healthcare professionals. The expert faculty will delve into the intricate relationship between comorbidities, cardiovascular risk factors, and anticancer therapies, with a specific focus on older adults. This event provides healthcare practitioners with valuable insights to address the unique challenges of caring for this vulnerable patient group. By enhancing clinical decision-making and patient care pathways, it empowers professionals to deliver comprehensive, patient-centered care to older adults facing the dual challenges of cancer and cardiovascular conditions.

The partnership combines Radcliffe’s rapidly growing global community and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits. 

This broadcast is for cardiologists, haematologists, oncologists, nurse practitioners, nurses and pharmacists.

The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS is collectively improving the overall outcomes including survival and quality of life. IC-OS aims to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.

The Multinational Association of Supportive Care in Cancer (MASCC) is an international, interdisciplinary organisation dedicated to the practice, education and research of supportive care in cancer. MASCC mission is to continually improve the supportive care of people with cancer – from diagnosis through to survival or end-of-life care.

Support Statement

This is an independent activity run by the International Cardio-Oncology Society (ICOS) and co-produced in collaboration with Radcliffe Cardiology. The IC-OS has been provided support to deliver this webinar series by AstraZeneca, BMS/Pfizer Alliance, Eli Lilly and Roche through an unrestricted educational grant to cover organisational costs and has had no input into the agenda or content of this educational activity. Radcliffe Cardiology has received no industry funding.